Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

Hepatology

Volumn 30, Issue 5, 1999, Pages 1302-1306

  Benhamou, Yves ^a,c   Bochet, Marie ^b   Thibault, Vincent ^c   Di Martino, Vincent ^a   Caumes, Eric ^b   Bricaire, Franois ^b   Opolon, Pierre ^a   Katlama, Christine ^b   Poynard, Thierry ^a  

^a Hop Pitie Salpetriere   (France)

^b Service des Maladies Infectieuses   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; DRUG EFFICACY; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR HYBRIDIZATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SUPERINFECTION; VIRUS INHIBITION; VIRUS LOAD;

ADULT; AMINO ACID SEQUENCE; ANTI-HIV AGENTS; COHORT STUDIES; DNA, VIRAL; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, MICROBIAL; HEPATITIS B; HEPATITIS B VIRUS; HIV INFECTIONS; HUMANS; LAMIVUDINE; MALE; POLYMERASE CHAIN REACTION;

EID: 0032760120     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300525     Document Type: Article

References (24)

1. Kane MA. Progress on the control of hepatitis B infection through immunisation. Gut 1993;34(Suppl):10S-12S.
2. Rustgi VK, Hoofnagle JH, Gerin JL, Gelmann EP, Reichert CM, Cooper JN, Macher AM, et al. Hepatitis B infection in the acquired immunodeficiency syndrome. Ann Intern Med 1984;101:795-797.
3. de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M. Survival and prognostic indicators of hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992;103:1630-1635.
4. Weissberg JI, Andres LL, Smith CI, Weick S, Nichols JE, Garcia G, et al. Survival in chronic hepatitis B. Ann Intern Med 1984;101:613-616.
5. Perrillo RP, Regenstein FG, Roodman ST. Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus. Ann Intern Med 1986;105:382-383.
6. MacDonald JA, Caruso L, Karayannis P, Scully J, Harris JRW, Forster GE, Thomas HC, et al. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV III antibodies to recombinant alpha interferon. HEPATOLOGY 1987;7:719-723.
7. Wong DK, Yim C, Naylor CD, Chen E, Sherman M, Vas S, Wanless IR, et al. Interferon alfa treatment of chronic hepatitis B: randomized trial in a predominantly homosexual male population. Gastroenterology 1995;108: 165-171.
8. Lai CL, Chien RN, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY, et al. A one year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61-68.
9. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin R. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995;333:1657-1661.
10. Benhamou Y, Katlama C, Lunel F, Coutellier A, Dohin E, Hamm N, Tubiana R, et al. The effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med 1996;125:705-712.
11. Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, Hawley S, et al. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. HEPATOLOGY 1999;29:889-896.
12. Tripples GA, Ma MM, Fisher KP, Bain VG, Kneteman M, Tyrrell DLJ. Mutation in HBV-DNA-dependent polymerase confers resistance to lamivudine in vivo. HEPATOLOGY 1996;24:714-717.
13. Bartholomew MM, Jansen RW, Lennox JJ, Jeffers J, Reddy KR, Johnson LC, Condreay LD, et al. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997;349:20-22.
14. Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, Harrison TJ. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. HEPATOLOGY 1996;24:3711-3713.
15. Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, Brown N, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. HEPATOLOGY 1998;27:1670-1677.
16. Chayama K, Suzuki Y, Kobayashi M, Kobayashi M, Tsubota A, Hashimoto M, Miyano Y, et al. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. HEPATOLOGY 1998;27: 1711-1716.
17. Niesters HG, Honkoop P, Haagsma EB, de Man RA, Schalm SW, Osterhaus AD. Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment. J Infect Dis 1998;177:1382-1385.
18. Pillay D, Bartholomeusz A, Cane P, Mutimer D, Schinazi RF, Locarnini S. Mutations in the hepatitis B virus DNA polymerase associated with antiviral resistance. Int Antiviral News 1998;6:167-169.
19. Center for Disease Control. 1993 Revised classification system for HIV infection and expanded AIDS surveillance case definition for adolescents and adults. Mor Mortal Wkly Rep CDC Surveill Summ 1992;41:2-4, 14-15.
20. Tisdale M, Kemp SD, Parry NR, Larder BA. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc Natl Acad Sci USA 1993;90:5653-5656.
21. Wainberg MA, Salomon H, Gu Z, Montaner JS, Cooley TP, McCaffrey R, Ruedy J, et al. Development of HIV-1 resistance to (2'-deoxy-3'-thiacytidine) in patients with AIDS or advanced AIDS-related complex. AIDS 1995;9:351-357.
22. Back NK, Nijhuis M, Keulen W, Boucher CA, Oude Essink BO, van Kuilenburg AB, van Gennip AH, et al. Reduced replication of 3TC- resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J 1996;15:4040-4049.
23. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, et al. Liver fibrosis progression in HIV and HCV coinfected patients. HEPATOLOGY 1999;30:1054-1058.
24. Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A, Degott C, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. HEPATOLOGY 1999;29:1306-1310.